# Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc. is a company headquartered in Stoneham, MA, United States.

## Company overview

- **Legal name:** Cyteir Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Stoneham, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001662244

## About

Cyteir Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662244, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-23, it reported net income of USD -46,061,000; total assets of USD 153,232,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$46.1M (USD -46,061,000)
- **Total assets:** $153.2M (USD 153,232,000)
- **Cash and equivalents:** $147.1M (USD 147,120,000)
- **Operating cash flow:** -$42.5M (USD -42,532,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$42.1M (USD -42,126,000)
- **Total assets:** $195.4M (USD 195,388,000)
- **Cash and equivalents:** $189.7M (USD 189,723,000)
- **Operating cash flow:** -$36.0M (USD -36,032,000)

## Recent SEC filings

- Form 8-K — filed 2024-03-20 — period 2024-03-20 — 8-K
- Form 8-K — filed 2024-03-07 — period 2024-03-07 — 8-K
- Form SC 13G — filed 2024-02-14
- Form 8-K — filed 2023-12-27 — period 2023-12-22 — 8-K
- Form 8-K — filed 2023-12-07 — period 2023-12-06 — 8-K
- Form 8-K — filed 2023-12-05 — period 2023-11-29 — 8-K
- Form 8-K — filed 2023-11-17 — period 2023-11-16 — 8-K
- Form 10-Q — filed 2023-11-06 — period 2023-09-30 — 10-Q
- Form SC 13G — filed 2023-11-03
- Form SC 13D — filed 2023-10-19
- Form 8-K — filed 2023-10-12 — period 2023-10-12 — 8-K
- Form 8-K — filed 2023-10-05 — period 2023-10-03 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/cyteir-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology